Drugs / recombinant human G-CSF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02915796 | Sep 2016 → Apr 2017 | peripheral arterial disease | Shanghai 10th People's Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant human G-CSF | “150 unit of recombinant human G-CSF intramuscular injection to mobilize CD 133 cells from bone marrow to peripheral blood” NCT02915796 ↗ |
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02915796 ↗ |
| Route | Intramuscular | “G-CSF intramuscular injection” NCT02915796 ↗ |